Search the PBPK Model Repository

Quickly find freely available drug and population models in our PBPK model repository.

The models provided have been collated from published examples which authors have shared in our Published Model Collection or developed as part of various global health projects in our Global Health Collection. This search facility searches both model collections simultaneously.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

|<

<

1

2

3

4

5

6

7

8

9

10

11

12

13

14

>

>|

Found 132 Matches

Curcumin_Japanese_V19R1_AstraZeneca_20210726
For curcumin, the Japanese population library file from the Simcyp Human Simulator was used, and a sulfotransferase clearance pathway was incorporated as published for the curcumin PBPK model (Physiologically-Based Pharmacokinetic Predictions of the Effect of Curcumin on Metabolism of Imatinib and Bosutinib: In Vitro and In Vivo Disconnect - PubMed (nih.gov)). The curcumin model used in the publication linked is also based on this earlier published model. Fugut=1 represents worst-case scenario DDI while Fugut=0.03 represents assumption that fu,gut = fu,whole blood.
Creatinine_MechKiM_V16R1_UniversityOfManchester_20210421
https://doi.org/10.1124/jpet.118.251413 Creatinine compound file with MechKiM
Carboxyprimaquine

Disease: Malaria

Drug Class: Antimalarials

Date Updated: March 2022

Related Files:  Primaquine (parent)

The model at-a-glance

  Absorption Model

N/A

  Volume of Distribution

Full PBPK (Method 2)

  Route of Elimination

  • Formed from primaquine by MAO. This is entered as ‘user-UGT’ as a surrogate within the simulator
  • Pathway of elimination is not defined; elimination is assigned as IV clearance that was manually optimized to fit the clinical data

  Perpetrator DDI

  • None

  Validation

  • Six clinical studies describing single and multiple dose exposure of carboxyprimaquine were used to verify the PBPK model.  The AUC for all verification studies were within 1.5-fold of the observed values.

  Limitations

  • Clinical data for carboxyprimaquine is highly variable

  Updates in V19

  • Converted from minimal PBPK model to full PBPK model

 

Ceftibuten_V14R1_AstraZeneca_20200327
Ceftibuten for pediatric predictions.

|<

<

1

2

3

4

5

6

7

8

9

10

11

12

13

14

>

>|